Darunavir Inhibitory Quotient Predicts the 48-Week Virological Response to Darunavir-Based Salvage Therapy in Human Immunodeficiency Virus-Infected Protease Inhibitor-Experienced Patients

The aim of this study was to evaluate the relationship between the virological response to darunavir-based salvage antiretroviral therapy and the darunavir genotypic and virtual inhibitory quotients (gIQ and vIQ, respectively). Thirty-seven HIV-infected patients failing protease inhibitor-based anti...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Moltó, José, Santos, José R., Pérez-Álvarez, Nuria, Cedeño, Samandhy, Miranda, Cristina, Khoo, Saye, Else, Laura, Llibre, Josep Maria, Valle, Marta, Clotet, Bonaventura
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology (ASM) 2008
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2573097/
https://ncbi.nlm.nih.gov/pubmed/18725446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00520-08
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы